Rho-kinase and In-stent Restenosis
CSTR:
Author:
  • Article
  • | |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • | |
  • Comments
    Abstract:

    ISR is essentially due to vascular smooth muscle cell (VSMC) proliferation and migration,and excessive extracellular matrix production,leading to neointima formation. Rho-kinase,a major regulator of VSMC proliferation and migration,after stenting plays its role in the neointimal formation.Long-term inhibition of Rho-kinase suppresses in-stent neointimal formation by multiple mechanisms. Inhibition of the Rho/Rho kinase pathway should provide a useful strategy to prevent ISR.

    Reference
    Related
    Cited by
Get Citation

WANG Jian-Hong, and LI Jing-Cheng. Rho-kinase and In-stent Restenosis[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2010,18(6):502-504.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:December 19,2009
  • Revised:April 13,2010
Article QR Code